EUVIMEDEUVIMED entdecken
Fallbericht

Human alveolar echinococcosis: consequences of discontinuation of albendazol treatment - a report of two cases

Jacek Czepiel, Jeremiasz Bik, Anna Królikowska, Martyna Lara, Mateusz Myśliwiec, Marcin Poręba, Grażyna Biesiada, Monika Bociaga-Jasik

Przeglad Epidemiologiczny · 2025

DOI: 10.32394/pe/207616 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Przeglad Epidemiologiczny, 2025. Verfasst von Jacek Czepiel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Jagiellonian University Collegium Medicum, Polska. Hauptthemen laut MEDLINE: Albendazole, Anthelmintics, Echinococcosis, Hepatic, Echinococcus multilocularis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alveolar echinococcosis (AE) is a rare and life-threatening parasitic infection caused by Echinococcus multilocularis. Nonspecific symptoms along with a lowered awareness of the disease among physicians often result in delayed diagnoses and subsequently limiting therapeutic options. Treatment of AE includes surgical resection with wide margins of healthy tissue combined with pharmacotherapy and close monitoring for recurrence. This paper presents two cases of patients who interrupted albendazole therapy administered after surgical removal of parasitic lesions. Both cases demonstrate that discontinuing albendazole therapy after non-radical echinococcal removal can lead to disease progression and life-threatening complications. Additionally, the report highlights socioeconomic challenges such as therapy accessibility, treatment costs, and patient education which can influence adherence to medical recommendations and treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbendazoleAnthelminticsEchinococcosis, HepaticEchinococcus multilocularisAnimalsHumansTreatment OutcomeEchinococcosis

Stichwörter der Autor:innen

Echinococcus multilocularisalbendazolalbendazolealweokokozahuman alveococcosisinterrupted therapyprzerwana terapia

Substanzen

AlbendazoleAnthelmintics

Autor:innen und Institutionen

  • Department of Infectious Diseases, Jagiellonian University Collegium Medicum, Polska.
  • Student Scientific Association at the Department of Infectious Diseases of the Jagiellonian University Collegium Medicum, Jagiellonian University Collegium Medicum, Polska.
  • University Hospital in Krakow, Department of Infectious Diseases, Polska.
  • Department of Infectious Diseases, Jagiellonian University Medical College, Polska.

Zitieren

APA

Czepiel, J., Bik, J., Królikowska, A., Lara, M., Myśliwiec, M., Poręba, M., Biesiada, G., & Bociaga-Jasik, M. (2025). Human alveolar echinococcosis: consequences of discontinuation of albendazol treatment - a report of two cases. Przeglad Epidemiologiczny. https://doi.org/10.32394/pe/207616

Vancouver

Czepiel J, Bik J, Królikowska A, Lara M, Myśliwiec M, Poręba M, et al. Human alveolar echinococcosis: consequences of discontinuation of albendazol treatment - a report of two cases. Przeglad Epidemiologiczny. 2025. doi:10.32394/pe/207616

BibTeX
@article{Czepiel2025,
  author = {Czepiel, Jacek and Bik, Jeremiasz and Królikowska, Anna and Lara, Martyna and Myśliwiec, Mateusz and Poręba, Marcin and Biesiada, Grażyna and Bociaga-Jasik, Monika},
  title = {Human alveolar echinococcosis: consequences of discontinuation of albendazol treatment - a report of two cases},
  journal = {Przeglad Epidemiologiczny},
  year = {2025},
  doi = {10.32394/pe/207616}
}
Kostenlos starten →